The JN.1 variant of COVID-19: immune evasion, transmissibility, and implications for global health

The emergence of the COVID-19 JN.1 variant has raised global health concerns as it gains prevalence in several regions worldwide. First identified in August 2023, JN.1 evolved from the Omicron lineage’s BA.2.86 subvariant. Patients infected with JN.1 commonly exhibit symptoms such as sore throat, fe...

Full description

Saved in:
Bibliographic Details
Main Authors: Araj Naveed Siddiqui, Imshaal Musharaf, Bashar Haruna Gulumbe
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Therapeutic Advances in Infectious Disease
Online Access:https://doi.org/10.1177/20499361251314763
Tags: Add Tag
No Tags, Be the first to tag this record!